TNFSF10 and pulmonary arterial hypertension: TRAIL immunoreactivity has been shown in pulmonary vascular lesions from idiopathic PAH patients (13) and increased TRAIL mRNA expression is detected in the lungs of rodent models of PAH (35, 38).